Clinical Trial: A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors

U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07130383) titled 'A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors' on Aug. 12.

Brief Summary: This is an open-label, multicenter Phase II study of MHB036C combined with MHB039A in patients with advanced Breast Cancer or other advanced malignant solid tumors. The study was designed to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of MHB036C and MHB039A combination therapy.

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: Advanced Breast Cancer Advanced Malignant Solid Tumor

Intervention: DRUG: MHB036C for Injection

Intravenous a...